Skip to main content
. 2013 Oct 30;99(1):172–180. doi: 10.3945/ajcn.113.068106

TABLE 3.

RRs (95% CIs) for mortality according to quintiles of the aMED among men and women with cardiovascular disease in the Health Professionals Follow-Up Study and the Nurses’ Health Study1

Q1 Q2 Q3 Q4 Q5 P-trend RR (95% CI) for a 2-point increase in the aMED score
Men
 Death from all causes
 Person-year 10,389 9920 9430 9248 9873
 Deaths (n) 460 437 367 380 338
 Age- and smoking-adjusted RR 1.0 0.88 (0.77, 1.00) 0.77 (0.67, 0.89) 0.80 (0.70, 0.92) 0.68 (0.59, 0.78) <0.001 0.86 (0.82, 0.91)
 Multivariable-adjusted RR 1.0 0.94 (0.82, 1.07) 0.85 (0.74, 0.98) 0.86 (0.75, 0.99) 0.79 (0.68, 0.91) 0.003 0.92 (0.86, 0.97)
 Death from cardiovascular disease
 Deaths (n) 268 240 213 235 186
 Age- and smoking-adjusted RR 1.0 0.84 (0.71, 1.01) 0.80 (0.66, 0.96) 0.88 (0.73, 1.05) 0.66 (0.54, 0.79) <0.001 0.87 (0.81, 0.94)
 Multivariable-adjusted RR 1.0 0.89 (0.75, 1.07) 0.88 (0.73, 1.05) 0.95 (0.79, 1.14) 0.77 (0.63, 0.93) 0.05 0.93 (0.86, 1.00)
 Death from cancer
 Deaths (n) 90 81 55 47 71
 Age- and smoking-adjusted RR 1.0 0.85 (0.63, 1.16) 0.61 (0.43, 0.86) 0.54 (0.38, 0.77) 0.78 (0.57, 1.07) 0.03 0.86 (0.75, 0.98)
 Multivariable-adjusted RR 1.0 0.91 (0.67, 1.24) 0.67 (0.47, 0.95) 0.58 (0.40, 0.83) 0.88 (0.63, 1.21) 0.14 0.90 (0.79, 1.03)
 Death from other causes
 Deaths (n) 102 5116 99 98 81
 Age- and smoking-adjusted RR 1.0 1.03 (0.79, 1.35) 0.90 (0.68, 1.20) 0.90 (0.68, 1.19) 0.72 (0.53, 0.97) 0.02 0.87 (0.78, 0.98)
 Multivariable-adjusted RR 1.0 1.11 (0.85, 1.46) 1.02 (0.77, 1.36) 0.98 (0.74, 1.30) 0.85 (0.63, 1.16) 0.27 0.94 (0.83, 1.05)
Women
 Death from all causes
 Person-year 15,494 16,160 16,055 15,769 16,279
 Deaths (n) 346 345 288 287 202
 Age- and smoking-adjusted RR 1.0 0.95 (0.82, 1.10) 0.82 (0.70, 0.96) 0.81 (0.69, 0.95) 0.60 (0.50, 0.71) <0.001 0.82 (0.76, 0.87)
 Multivariable-adjusted RR 1.0 1.03 (0.89, 1.20) 0.95 (0.81, 1.11) 1.01 (0.86, 1.19) 0.85 (0.71, 1.02) 0.11 0.95 (0.88, 1.01)
 Death from cardiovascular disease
 Deaths (n) 141 158 141 131 95
 Age- and smoking-adjusted RR 1.0 1.05 (0.83, 1.32) 0.97 (0.77, 1.23) 0.90 (0.71, 1.14) 0.68 (0.52, 0.88) 0.002 0.86 (0.78, 0.94)
 Multivariable-adjusted RR 1.0 1.15 (0.91, 1.45) 1.13 (0.89, 1.44) 1.15 (0.90, 1.46) 0.99 (0.75, 1.29) 0.87 1.01 (0.91, 1.11)
 Death from cancer
 Deaths (n) 43 39 47 42 26
 Age- and smoking-adjusted RR 1.0 0.85 (0.55, 1.31) 1.12 (0.74, 1.70) 1.00 (0.65, 1.54) 0.67 (0.41, 1.10) 0.14 0.87 (0.73, 1.04)
 Multivariable-adjusted RR 1.0 0.87 (0.56, 1.36) 1.20 (0.79, 1.84) 1.12 (0.72, 1.74) 0.80 (0.48, 1.33) 0.48 0.94 (0.78, 1.13)
 Death from other causes
 Deaths (n) 16 148 100 114 81
 Age- and smoking-adjusted RR 1.0 0.89 (0.71, 1.12) 0.61 (0.48, 0.79) 0.69 (0.54, 0.88) 0.52 (0.39, 0.68) <0.001 0.76 (0.68, 0.84)
 Multivariable-adjusted RR 1.0 0.97 (0.77, 1.22) 0.70 (0.54, 0.91) 0.85 (0.67, 1.09) 0.75 (0.56, 0.98) 0.02 0.88 (0.79, 0.97)
Pooled results2
 Death from all causes 1 0.98 (0.89, 1.08) 0.90 (0.81, 1.00) 0.94 (0.81, 1.08) 0.81 (0.72, 0.91) <0.001 0.93 (0.89, 0.97)
 Death from cardiovascular disease 1 1.00 (0.79, 1.27) 0.99 (0.78, 1.25) 1.02 (0.87, 1.21) 0.85 (0.67, 1.09) 0.30 0.96 (0.89, 1.04)
 Death from cancer 1 0.89 (0.69, 1.15) 0.88 (0.50, 1.55) 0.80 (0.42, 1.54) 0.85 (0.65, 1.11) 0.10 0.91 (0.82, 1.02)
 Death from other causes 1 1.03 (0.86, 1.22) 0.84 (0.59, 1.22) 0.91 (0.75, 1.09) 0.79 (0.65, 0.97) 0.01 0.91 (0.84, 0.98)
1

Adjusted for age (1-y increment), smoking status (never, past, or current 1–14, 15–24, or ≥25 cigarettes/d), BMI (in kg/m2; <23.0, 23.0–24.9, 25.0–27.9, 28.0–29.9, or ≥30.0), leisure-time physical activity (<1.5, 1.5–5.9, 6.0–11.9, 12.0–20.9, or ≥21.0 MET-h/wk), parental history of myocardial infarction before age 65 y, menopausal status and use of HT in women (premenopausal women, postmenopausal without HT, postmenopausal with past HT, or postmenopausal with current HT), multivitamin use, and medication use (aspirin, diuretics, β-blockers, calcium channel blockers, other blood pressure medication, or statins and other cholesterol-lowering drugs). aMED, Alternate Mediterranean Diet; HT, hormone therapy; MET, metabolic equivalent task; Q, quintile.

2

Results from the multivariable-adjusted models were combined by using a random-effects model.